Doxycycline Hyclate
Sponsors
Warner Chilcott, Metropolitan Autonomous University, Sun Yat-sen University, Unity Health Toronto, University of Alberta
Conditions
AcneAcne VulgarisAutoimmune DiseasesBacterial Sexually Transmitted DiseasesEndocrine System DiseasesExudative Macular DegenerationEye Diseases, HereditaryGraves Disease
Phase 2
Double-blind-randomized,Placebo Controlled Trial for Chemotherapy-associated Oral Mucositis Using Doxycycline Hyclate
NCT01087476
Start: 2010-05-31End: 2013-02-28Target: 164Updated: 2010-03-16
Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy
NCT02203682
Start: 2014-07-31End: 2022-07-31Target: 100Updated: 2021-11-17
Doxycycline for Hereditary Hemorrhagic Telangiectasia
CompletedNCT03397004
Start: 2018-09-12End: 2021-03-01Updated: 2025-04-01
Doxycycline to Protect Heart Muscle After Heart Attacks
CompletedNCT03508232
Start: 2020-01-06End: 2025-08-26Updated: 2026-04-13
MMP-9 Inhibition for Recalcitrant Wet AMD
RecruitingNCT04504123
Start: 2020-11-04End: 2027-03-01Target: 50Updated: 2026-04-02
Phase 4
Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate
CompletedNCT00635609
Start: 2008-03-31End: 2008-09-30Updated: 2012-04-20
A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)
CompletedNCT04451330
Start: 2020-07-29End: 2021-04-26Updated: 2022-05-10
Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne
Active, not recruitingNCT04582383
Start: 2022-03-30End: 2027-07-31Target: 350Updated: 2026-08-25
Subantimicrobial Doxycycline in Acne
CompletedNCT05399290
Start: 2020-11-19End: 2021-11-08Updated: 2023-04-03